Literature DB >> 1610216

Human T lymphocytes and T-cell lines as target cells for lymphocyte chemotaxis.

C O Zachariae1, K Kaltoft, K Thestrup-Pedersen.   

Abstract

We have observed that freshly isolated T lymphocytes from healthy donors give a chemotactic response to complement C5a in 26 of 55 individuals and to epidermal lymphocyte chemotactic factor in 15 of 23 donors using 51chromium-labelled lymphocytes in a double-filter Boyden chamber system. The reason for a lack of demonstrable chemotaxis among some cell populations is unknown, but it makes donor selection important when studying lymphocyte chemotaxis. In order to obtain a standardized screening assay for T lymphocyte chemotactic activity, we investigated a number of T-cell lines or T-cell-related cell lines such as HuT78, Jurkat, MOLT4, K562 and 1301. We observed that HuT78, K562 and Jurkat showed chemotactic responses to a variety of mediators, whereas 1301 showed chemotaxis only towards C5a, and MOLT4 was completely negative. The HuT78 cell line, which is derived from a patient with Sézary's syndrome, exhibited the highest chemotactic capacity similar to freshly isolated T lymphocytes. The only difference was its chemotactic response towards stimulation with recombinant interleukin-1 alpha and beta, which did not induce chemotaxis in human peripheral blood T lymphocytes in the Boyden chamber assay. We conclude that HuT78 can be used in screening various inflammatory mediators for their potential T lymphocyte chemotactic properties.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610216     DOI: 10.1007/bf00373373

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  16 in total

1.  Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers.

Authors:  D Haskard; D Cavender; M Ziff
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Motility of murine lymphocytes during transit through cell cycle. Analysis by a new in vitro assay.

Authors:  S Ratner; R K Jasti; G H Heppner
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

3.  Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation.

Authors:  C van Noesel; F Miedema; M Brouwer; M A de Rie; L A Aarden; R A van Lier
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

4.  Endothelium-lymphocyte interactions in vitro. II. Adherence of allergized lymphocytes.

Authors:  D de Bono
Journal:  Cell Immunol       Date:  1979-04       Impact factor: 4.868

5.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

6.  Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets.

Authors:  R Pardi; J R Bender; C Dettori; E Giannazza; E G Engleman
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

7.  Expression of interleukin 1 receptors on human peripheral T cells.

Authors:  F Shirakawa; Y Tanaka; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Phorbol ester treatment enhances binding of mononuclear leukocytes to autologous and allogeneic gamma-interferon-treated keratinocytes, which are blocked by anti-LFA-1 monoclonal antibody.

Authors:  B J Nickoloff; R S Mitra
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551

9.  Differential expression of lymphocyte function-associated antigen 1 (LFA-1) on epidermotropic and non-epidermotropic T-cell clones.

Authors:  T Shiohara; N Moriya; C Gotoh; J Hayakawa; K Saizawa; H Yagita; M Nagashima
Journal:  J Invest Dermatol       Date:  1989-12       Impact factor: 8.551

10.  Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody.

Authors:  D E Van Epps; J Potter; M Vachula; C W Smith; D C Anderson
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

View more
  4 in total

1.  Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter.

Authors:  L F Lee; J S Haskill; N Mukaida; K Matsushima; J P Ting
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 2.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor.

Authors:  C O Zachariae; T Jinquan; V Nielsen; K Kaltoft; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

4.  Characterization of Functional Effects of Two New Active Fractions Isolated From Scorpion Venom on Neuronal Ca2+ Spikes: A Possible Action on Ca2+-Dependent Dependent K+ Channels.

Authors:  Hanieh Tamadon; Zahra Ghasemi; Fatemeh Ghasemi; Narges Hosseinmardi; Hossein Vatanpour; Mahyar Janahmadi
Journal:  Basic Clin Neurosci       Date:  2019-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.